Insulet, a developer of tubeless insulin pump technology, stated that its Omnipod Insulin Management System (Omnipod System) has received (International Standards Organization) 27001 certification of its Omnipod DASH System.
Image: Insulet’s Omnipod DASH receives ISO 27001 Certification. Photo: Courtesy of Erik Araujo/FreeImages.com
ISO 27001 certification is the international standard for best practice in an information security management system globally. Insulet also recently announced that the Company received the DTSec (Diabetes Technology Society’s) Cybersecurity Standard for Connected Diabetes Device Security certification for the Omnipod DASH System. Insulet is the only insulin pump company to receive both certifications.
ISO 27001 is an internationally recognized standard for information security best practice that adheres to the highest international data security standards. DTSec leverages ISO/IEC 15408 to provide a framework for risk-based, multi-stakeholder definition of security requirements. The Omnipod DASH System, Insulet’s next-generation platform, was designed to be the foundation for the Company’s future innovation.
With the ISO 27001 and DTSec certifications, the Omnipod DASH System is now globally recognized for incorporating the highest standards for information and cyber security and safety, including secure data transfer between the Pod and the personal diabetes manager (PDM), as well as secure cloud storage.
Insulet executive vice president and chief technology officer Aiman Abdel-Malek said “This is part of a large-scale organizational commitment to ensure the highest-level of cyber security of our Omnipod DASH System and to provide information security our Podders can trust.
“We are committed to remaining at the forefront of best-in-class standards to secure patients’ safety and privacy. Our compliance with these internationally recognized standards sets us apart from others in the global insulin pump market and provides our users with further peace of mind that they can rely on a highly safe and secure product to manage their diabetes.”
Insulet’s Omnipod DASH System received FDA clearance in June this year and is currently in limited market commercial release. The Company expects to fully launch the product commercially in early next year.
Source: Company Press Release